ZipRecruiter reported strong Q3 results, surpassing revenue and earnings per share expectations while returning to profitability. The company saw a 10% year-over-year increase in paid employers, with some monetization timing effects noted. Gross margin improved to 89.8%, and GAAP operating margin rose by 13.1 percentage points. ZipRecruiter also reduced debt significantly and generated $22 million in free cash flow year-to-date. Product upgrades, including a new matching engine and the Be Seen First feature, boosted qualified applications by 49% sequentially, indicating strong operational momentum and differentiation in the market. These improvements support an upgraded buy rating for the stock.
ZipRecruiter Q3 stock update provides context for readers interested in technology stocks. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 20:03 WIB: out of 150 priced Technology-sector US stocks tradable on Pluang, 40 rose and 101 fell today. Notable movers include RGTI at USD 12.43 with a -4.24% change and 74% sell activity, APLD at USD 16.05 with a -4.01% change and 59% buy activity, and MRVL at USD 148.42 with a -4.00% change and 61% buy activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
